Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm

general

A primary malignant neoplasm of the uterine corpus characterized by the presence of an epithelial and a mesenchymal component. This category includes carcinosarcoma, carcinofibroma, and adenosarcoma.

Centers

Active Trials

$1.4B

Cancer Funding

Specific Cancer Types(1)

Name	Centers	Active Trials
Endometrial Carcinosarcoma	6	2

Top Centers for Malignant Uterine Corpus Mixed Epithelial and Mesenchymal Neoplasm(13)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive	—	—	54.5
2	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive	—	—	54.5
3	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	54.5
4	Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive	—	—	54.5
5	Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, IN NCI Comprehensive	—	—	54.5
6	Cleveland Clinic Cancer CenterCleveland, OH	—	—	54.5
7	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive	—	—	54.5
8	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical	—	—	54.5
9	University of Illinois Cancer CenterChicago, IL	—	—	54.5
10	Cancer Center at IllinoisUrbana, IL	—	—	54.5
11	Stony Brook Cancer CenterStony Brook, NY	—	—	54.5
12	Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive	2	$911M	—
13	Duke Cancer InstituteDurham, NC NCI Comprehensive	—	$454M	—

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →